{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T13:09:01Z","timestamp":1794834541436,"version":"4.9.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.repc.2023.07.010","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T11:38:46Z","timestamp":1703245126000},"page":"203-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cirrhotic cardiomyopathy: Pathogenesis, clinical features, diagnosis, treatment and prognosis"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8947-4049","authenticated-orcid":false,"given":"Francisca","family":"Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2023.07.010_bib0385","first-page":"e27969","article-title":"Cirrhotic cardiomyopathy: the interplay between liver and heart","volume":"14","author":"Kalluru","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.repc.2023.07.010_bib0390","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11894-020-00783-1","article-title":"Cirrhotic cardiomyopathy","volume":"22","author":"Yoon","year":"2020","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.repc.2023.07.010_bib0395","doi-asserted-by":"crossref","first-page":"15492","DOI":"10.3748\/wjg.v20.i42.15492","article-title":"Cirrhotic cardiomyopathy: a cardiologist's perspective","volume":"20","author":"Gassanov","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.repc.2023.07.010_bib0400","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrgastro.2013.210","article-title":"Cirrhotic cardiomyopathy: pathogenesis and clinical relevance","volume":"11","author":"Wiese","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.repc.2023.07.010_bib0405","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00392-013-0610-1","article-title":"Does cirrhotic cardiomyopathy exist? 50 years of uncertainty","volume":"102","author":"Pellicori","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.repc.2023.07.010_bib0410","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.transproceed.2011.01.188","article-title":"A perspective on cirrhotic cardiomyopathy","volume":"43","author":"Timoh","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.repc.2023.07.010_bib0415","first-page":"530","article-title":"Cardiac abnormalities in liver cirrhosis","volume":"151","author":"Lee","year":"1989","journal-title":"West J Med"},{"key":"10.1016\/j.repc.2023.07.010_bib0420","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jceh.2021.11.005","article-title":"A prospective study of prevalence and predictors of cirrhotic cardiomyopathy and its role in development of hepatorenal syndrome","volume":"12","author":"Anikhindi","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.repc.2023.07.010_bib0425","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jhep.2004.09.008","article-title":"Cardiac alterations in cirrhosis: reversibility after liver transplantation","volume":"42","author":"Torregrosa","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.repc.2023.07.010_bib0430","first-page":"206","article-title":"Cirrhotic cardiomyopathy","volume":"98","author":"Elleuch","year":"2020","journal-title":"Tunis Med"},{"key":"10.1016\/j.repc.2023.07.010_bib0435","doi-asserted-by":"crossref","first-page":"970","DOI":"10.23736\/S0375-9393.18.12343-1","article-title":"Hepatic encephalopathy and cirrhotic cardiomyopathy in Intensive Care Unit","volume":"84","author":"Scarpati","year":"2018","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.repc.2023.07.010_bib0440","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/liv.14769","article-title":"The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria","volume":"41","author":"Razpotnik","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.repc.2023.07.010_bib0445","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.510240226","article-title":"Cirrhotic cardiomyopathy: getting to the heart of the matter","volume":"24","author":"Ma","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.repc.2023.07.010_bib0450","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jjcc.2015.04.016","article-title":"Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase","volume":"67","author":"Zardi","year":"2016","journal-title":"J Cardiol"},{"key":"10.1016\/j.repc.2023.07.010_bib0455","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.transproceed.2016.01.010","article-title":"Diastolic dysfunction in liver cirrhosis: prognostic predictor in liver transplantation?","volume":"48","author":"Carvalheiro","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.repc.2023.07.010_bib0460","doi-asserted-by":"crossref","first-page":"G275","DOI":"10.1152\/ajpgi.00094.2017","article-title":"Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis","volume":"314","author":"Busk","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.repc.2023.07.010_bib0465","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gin\u00e8s","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.repc.2023.07.010_bib0470","doi-asserted-by":"crossref","first-page":"203794","DOI":"10.1155\/2012\/203794","article-title":"Clinical manifestations of portal hypertension","volume":"2012","author":"Al-Busafi","year":"2012","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.repc.2023.07.010_bib0475","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","article-title":"Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis","volume":"38","author":"Ruiz-del-Arbol","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.repc.2023.07.010_bib0480","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.repc.2023.07.010_bib0485","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/liv.13589","article-title":"The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis","volume":"38","author":"M\u00f8ller","year":"2018","journal-title":"Liver Int"},{"issue":"Pt 1","key":"10.1016\/j.repc.2023.07.010_bib0490","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.1840120306","article-title":"Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats","volume":"12","author":"Lee","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.repc.2023.07.010_bib0495","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/hep.510250610","article-title":"Cardiac muscarinic receptor function in rats with cirrhotic cardiomyopathy","volume":"25","author":"Jaue","year":"1997","journal-title":"Hepatology"},{"issue":"Pt 1","key":"10.1016\/j.repc.2023.07.010_bib0500","first-page":"G87","article-title":"Membrane physical properties determine cardiac beta-adrenergic receptor function in cirrhotic rats","volume":"267","author":"Ma","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.repc.2023.07.010_bib0505","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/hep.22533","article-title":"An abnormal gene expression of the beta-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats","volume":"48","author":"Ceolotto","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.repc.2023.07.010_bib0510","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1042\/cs1020213","article-title":"Nitric oxide and renal and cardiac dysfunction in cirrhosis","volume":"102","author":"Garc\u00eda-Esta\u00f1","year":"2002","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.repc.2023.07.010_bib0515","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0016-5085(00)70180-6","article-title":"Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats","volume":"118","author":"Liu","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.repc.2023.07.010_bib0520","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ncpgasthep0498","article-title":"Therapy insight: cirrhotic cardiomyopathy","volume":"3","author":"Gaskari","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.repc.2023.07.010_bib0525","doi-asserted-by":"crossref","first-page":"G68","DOI":"10.1152\/ajpgi.2001.280.1.G68","article-title":"Role of heme oxygenase\u2013carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat","volume":"280","author":"Liu","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.repc.2023.07.010_bib0530","first-page":"195","article-title":"The endocannabinoid system and its role in the pathogenesis and treatment of cardiovascular disturbances in cirrhosis","volume":"76","author":"M\u0103ries","year":"2013","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.repc.2023.07.010_bib0535","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.phrs.2009.04.003","article-title":"Endocannabinoids and cardiac contractile function: pathophysiological implications","volume":"60","author":"B\u00e1tkai","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.repc.2023.07.010_bib0540","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/89953","article-title":"Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis","volume":"7","author":"B\u00e1tkai","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.repc.2023.07.010_bib0545","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bjp.0706331","article-title":"Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats","volume":"146","author":"Gaskari","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.repc.2023.07.010_bib0550","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jhep.2010.03.011","article-title":"Mechanisms of TNF\u03b1-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNF\u03b1 and endocannabinoids","volume":"53","author":"Yang","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.repc.2023.07.010_bib0555","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.01.021","article-title":"Blunted cardiac response to hemorrhage in cirrhotic rats is mediated by local macrophage-released endocannabinoids","volume":"62","author":"Gaskari","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.repc.2023.07.010_bib0560","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.beem.2008.10.009","article-title":"The role of the endocannabinoid system in liver diseases","volume":"23","author":"Caraceni","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.repc.2023.07.010_bib0565","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1053\/gast.2001.28653","article-title":"Altered cellular calcium regulatory systems in a rat model of cirrhotic cardiomyopathy","volume":"121","author":"Ward","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.repc.2023.07.010_bib0570","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/lt.24768","article-title":"Cirrhotic cardiomyopathy: implications for liver transplantation","volume":"23","author":"Liu","year":"2017","journal-title":"Liver Transpl"},{"key":"10.1016\/j.repc.2023.07.010_bib0575","doi-asserted-by":"crossref","first-page":"100821","DOI":"10.1016\/j.cpcardiol.2021.100821","article-title":"Diagnosis and prevalence of cirrhotic cardiomyopathy: a systematic review and meta-analysis","volume":"46","author":"Shahvaran","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.repc.2023.07.010_bib0580","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.30875","article-title":"Redefining cirrhotic cardiomyopathy for the modern era","volume":"71","author":"Izzy","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.repc.2023.07.010_bib0585","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1540-8167.2006.00622.x","article-title":"QT interval correction in patients with cirrhosis","volume":"18","author":"Zambruni","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.repc.2023.07.010_bib0590","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1586\/egh.11.86","article-title":"QT interval prolongation in liver cirrhosis: innocent bystander or serious threat?","volume":"6","author":"Bernardi","year":"2012","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.repc.2023.07.010_bib0595","doi-asserted-by":"crossref","first-page":"622","DOI":"10.12659\/AOT.908769","article-title":"Pretransplant QT interval: the relationship with severity and etiology of liver disease and prognostic value after liver transplantation","volume":"23","author":"G\u0142\u00f3wczy\u0144ska","year":"2018","journal-title":"Ann Transplant"},{"key":"10.1016\/j.repc.2023.07.010_bib0600","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/ctr.12778","article-title":"Impact and persistence of cirrhotic cardiomyopathy after liver transplantation","volume":"30","author":"Sonny","year":"2016","journal-title":"Clin Transplant"},{"key":"10.1016\/j.repc.2023.07.010_bib0605","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1111\/ajt.16500","article-title":"Relationship between QT interval prolongation and structural abnormalities in cirrhotic cardiomyopathy: a change in the current paradigm","volume":"21","author":"Koshy","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.repc.2023.07.010_bib0610","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0168-8278(02)00010-7","article-title":"Dyssynchronous electrical and mechanical systole in patients with cirrhosis","volume":"36","author":"Henriksen","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.repc.2023.07.010_bib0615","first-page":"539412","article-title":"The end-organ impairment in liver cirrhosis: appointments for critical care","volume":"2012","author":"Figueiredo","year":"2012","journal-title":"Crit Care Res Pract"},{"key":"10.1016\/j.repc.2023.07.010_bib0620","doi-asserted-by":"crossref","first-page":"665","DOI":"10.15403\/jgld-3137","article-title":"Cirrhotic cardiomyopathy in the era of liver transplantation: time for precise stepwise evaluation","volume":"29","author":"Rimba\u0219","year":"2020","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.repc.2023.07.010_bib0625","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1532-429X-12-47","article-title":"Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis","volume":"12","author":"Lossnitzer","year":"2010","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.repc.2023.07.010_bib0630","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1148\/radiol.2020201057","article-title":"Myocardial fibrosis and inflammation in liver cirrhosis: MRI study of the liver\u2013heart axis","volume":"297","author":"Isaak","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.repc.2023.07.010_bib0635","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.19082\/1984","article-title":"Brain natriuretic peptide in liver cirrhosis and fatty liver: correlation with cardiac performance","volume":"8","author":"Metwaly","year":"2016","journal-title":"Electron Physician"},{"key":"10.1016\/j.repc.2023.07.010_bib0640","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/hep.31661","article-title":"Prognostic value of B-type natriuretic peptide in liver transplant patients: implication in posttransplant mortality","volume":"74","author":"Kwon","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.repc.2023.07.010_bib0645","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1432-2277.2011.01219.x","article-title":"High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients","volume":"24","author":"Saner","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.repc.2023.07.010_bib0650","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1478-3231.2010.02266.x","article-title":"B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis","volume":"30","author":"Pimenta","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.repc.2023.07.010_bib0655","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/jgh.13902","article-title":"Elevated cardiac troponin T in cirrhotic patients with emergency care admissions: associations with mortality","volume":"33","author":"Elnegouly","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.repc.2023.07.010_bib0660","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4097\/kja.20296","article-title":"Preoperative high-sensitivity troponin I and B-type natriuretic peptide, alone and in combination, for risk stratification of mortality after liver transplantation","volume":"74","author":"Moon","year":"2021","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.repc.2023.07.010_bib0665","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3343\/alm.2018.38.4.306","article-title":"Galectin-3 reflects the echocardiographic grades of left ventricular diastolic dysfunction","volume":"38","author":"Ansari","year":"2018","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.repc.2023.07.010_bib0670","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/1753944717727498","article-title":"Left atrial volume index in patients with heart failure and severely impaired left ventricular systolic function: the role of established echocardiographic parameters, circulating cystatin C and galectin-3","volume":"11","author":"Zivlas","year":"2017","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.repc.2023.07.010_bib0675","doi-asserted-by":"crossref","first-page":"367","DOI":"10.5152\/tjg.2016.16100","article-title":"Galactin-3 and brain natriuretic peptide versus conventional echocardiography in the early detection of cirrhotic cardiomyopathy","volume":"27","author":"Abbas","year":"2016","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.repc.2023.07.010_bib0680","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.repc.2014.10.005","article-title":"Galectin-3, a prognostic marker \u2013 and a therapeutic target?","volume":"34","author":"Pereira","year":"2015","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.repc.2023.07.010_bib0685","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3350\/cmh.2021.0141","article-title":"Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats","volume":"28","author":"Yoon","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.repc.2023.07.010_bib0690","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2023.07.010_bib0695","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.CIR.49.4.755","article-title":"Impaired left ventricular function in alcoholic cirrhosis with ascites. Ineffectiveness of ouabain","volume":"49","author":"Limas","year":"1974","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2023.07.010_bib0700","first-page":"4","article-title":"Evaluation of chronic losartan treatment effect on cardiac chronotropic dysfunction in biliary cirrhotic rats","volume":"56","author":"Jazaeri","year":"2018","journal-title":"Acta Med Iran"},{"key":"10.1016\/j.repc.2023.07.010_bib0705","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1572-0241.2005.41060.x","article-title":"Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosis","volume":"100","author":"Pozzi","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.repc.2023.07.010_bib0710","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/MEG.0000000000001128","article-title":"\u03b2-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial","volume":"30","author":"Silvestre","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.repc.2023.07.010_bib0715","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jhep.2017.02.005","article-title":"Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites","volume":"67","author":"Sinha","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.repc.2023.07.010_bib0720","doi-asserted-by":"crossref","first-page":"e0270603","DOI":"10.1371\/journal.pone.0270603","article-title":"Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: relation to severity?","volume":"17","author":"Nabilou","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.repc.2023.07.010_bib0725","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2023.07.010_bib0730","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/MCG.0000000000001219","article-title":"Carvedilol combined with ivabradine improves left ventricular diastolic dysfunction, clinical progression, and survival in cirrhosis","volume":"54","author":"Premkumar","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.repc.2023.07.010_bib0735","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/lt.26000","article-title":"Cirrhotic cardiomyopathy predicts posttransplant cardiovascular disease: revelations of the new diagnostic criteria","volume":"27","author":"Izzy","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.repc.2023.07.010_bib0740","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/hep.30040","article-title":"Cirrhotic cardiomyopathy after transplantation: neither the transient nor innocent bystander","volume":"68","author":"Izzy","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.repc.2023.07.010_bib0745","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/hep.29329","article-title":"A point-based prediction model for cardiovascular risk in orthotopic liver transplantation: the CAR-OLT score","volume":"66","author":"VanWagner","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.repc.2023.07.010_bib0750","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-1172-2-15","article-title":"Cirrhotic cardiomyopathy","volume":"2","author":"Baik","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.repc.2023.07.010_bib0755","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12664-020-01083-2","article-title":"Prevalence of cirrhotic cardiomyopathy and its relationship with serum pro-brain natriuretic peptide, hepatorenal syndrome, spontaneous bacterial peritonitis, and mortality","volume":"39","author":"Kapoor","year":"2020","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.repc.2023.07.010_bib0760","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1572-0241.2002.05438.x","article-title":"Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS)","volume":"97","author":"Merli","year":"2002","journal-title":"Am J Gastroenterol"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255123005000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255123005000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T07:46:28Z","timestamp":1711525588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255123005000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0870255123005000"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2023.07.010","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cirrhotic cardiomyopathy: Pathogenesis, clinical features, diagnosis, treatment and prognosis","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2023.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}